Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi's sarcoma.
暂无分享,去创建一个
M. Landthaler | A. Goetz | M. Landthaler | S. Karrer | W. Bäumler | R. Szeimies | C. Abels | A. E. Goetz | C. Abels | S. Karrer | W. Bäumler | R. M. Szeimies | A. Goetz | W. Bäumler | Rolf-Markus Szeimies | Christoph Abels | M. Landthaler
[1] A. Dalgleish,et al. Kaposi's sarcoma. , 1991, British Journal of Cancer.
[2] R. Lilenbaum,et al. Systemic treatment of Kaposi's sarcoma: current status and future directions. , 1994, AIDS.
[3] R. Speich,et al. Anaphylactoid reactions after indocyanine-green administration. , 1988, Annals of internal medicine.
[4] J. Denekamp,et al. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy , 1993 .
[5] T. J. Muckle,et al. Plasma proteins binding of indocyanine green. , 1976, Biochemical medicine.
[6] G. Paumgartner. The handling of indocyanine green by the liver. , 1975, Schweizerische medizinische Wochenschrift.
[7] P. Lund-johansen,et al. The dye dilution method for measurement of cardiac output. , 1990, European heart journal.
[8] V. Beral,et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? , 1990, The Lancet.
[9] Fox Ij,et al. Indocyanine green: physical and physiologic properties. , 1960, Proceedings of the staff meetings. Mayo Clinic.
[10] M. Haller,et al. Determination of plasma volume with indocyanine green in man. , 1993, Life sciences.
[11] A. deScoville. [Kaposi's sarcoma]. , 1973 .